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Abstract Diffusion tensor imaging was used to study brain
related changes in white matter that may be associated with
Huntington’s Disease progression. Thirty-one preclinical
gene-mutation carriers were imaged cross-sectionally using
diffusion tensor and anatomical brain imaging. Subjects
were individuals who had a known gene mutation for HD
but did not manifest motor diagnostic criteria for HD.
Fractional anisotropy scalar maps showed a positive
correlation with five year probability of diagnosis (based
upon gene repeat length and current age) in the putamen
and a negative correlation in the external capsule. This
study shows that scalar maps generated from diffusion
tensor imaging may be directly related to the earliest stages
of disease progression within HD, even before a diagnosis
is given. Findings suggest that DTI measures, therefore,
may have the ability to act as a biomarker for disease
progression in clinical trials of pre-manifest subjects.
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Introduction
Huntington’s disease (HD) is an important neurodegenerative
disease by virtue of its hereditary nature, grave clinical
manifestations and devastating impact on families. HD is an
autosomal dominantly inherited disorder characterized by
progressive abnormalities of motor and emotional control,
cognitive ability, and by involuntary (choreoathetoid) move-
ments. The disease typically strikes in the fourth decade of
life, but there is a wide range in age of onset, from childhood
to greater than 75 years (Martin 1984). The typical duration
from disease diagnosis to death is 15 to 20 years. Neuro-
degeneration in the HD brain primarily affects the caudate
and putamen, but widespread neuronal loss in the cortex and
other brain regions have been reported (Cudkowicz &
Kowall 1990). The primary radiographic features of HD
are caudate and putamen atrophy which can be measured
prior to the motor manifestation of disease in some gene-
mutation carriers (Paulsen et al. 2007). Although more
widespread imaging abnormalities had been noted for over
a decade (Jernigan et al. 1991) involvement of the extra-
striatal measures did not receive much attention until
recently. Several publications from different imaging groups
have noted disproportionate white matter loss compared to
grey matter volume in HD (Aylward et al. 1998; Beglinger
et al. 2005; Rosas et al. 2003). Importantly, Beglinger and
her colleagues reported that significant white matter abnor-
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mality was more highly associated with cognitive impair-
ment than striatal atrophy, suggesting a particular importance
for white matter integrity in the clinical manifestations of HD
(Beglinger et al. 2005).
Given the white matter reduction consistently cited
across studies, a few groups have recently examined
whether a noninvasive modality capable of probing early
changes of injured myelin and axons could be beneficial in
characterizing early brain changes associated with HD.
Diffusion tensor magnetic resonance imaging (DT-MRI) is
a recent development providing detailed information about
the degree of coherence of neuronal fiber alignment,
microstructural integrity, and potentially of white matter
connectivity of the brain in vivo. In a diffusion-weighted
MR image (DWI), image contrast is determined by the
Brownian motion of water molecules (Le Bihan et al.
1986). Anisotropic water diffusion is a property of
preferential molecular diffusion in the direction of the
fibers running in parallel. In contrast, diffusion is relatively
restricted across them. Normal white matter tracts with
coherently oriented fibers show high diffusion anisotropy.
The basis for changes in diffusion tensor signal is related to
the underlying fiber architecture and density, coherence of
nerve fiber orientation, and axonal membranes. Measurable
decreases in anisotropy have been observed in many
pathological processes that cause changes at the micro-
structural level, such as demyelination and corruption of
microtubules, leading to diminished intravoxel fiber coher-
ence. In DT-MRI, diffusion anisotropy effects of DWI data
are further exploited utilizing a number of diffusion-
sensitizing gradients with different angular orientations in
order to encode axonal fiber directions (Basser 1995).
Diffusion tensor imaging has been applied to studies of
brain diseases including cerebral ischemia and infarction,
white matter degenerative disorders, Alzheimer’s disease
(AD), mild cognitive impairment (MCI), multiple sclerosis
(MS), traumatic brain injury, and schizophrenia. For
example, in MS, diffusion tensor scalars have been shown
to reflect axonal attenuation and demyelination (Hesseltine
et al. 2006). Work by Parente et al. using DT-MRI to study
AD and MCI (Parente et al. 2008), however, showed that
wallerian degeneration secondary to cortical neuronal loss
is the primary reason for white matter changes in AD, while
myelin breakdown, white matter rarefaction, axonal dam-
age, and gliosis are likely the cause of white matter changes
associated with MCI. These studies indicate that DT-MRI
can provide insights into pathophysiological mechanisms,
even in cases with early disease, such as MCI.
A few recent studies have examined DTI in manifest and
preclinical HD. Reading et al. (Reading et al. 2005) first
employed the use of DT-MRI to examine changes in white
matter in small number of preclinical HD subjects (n=7) as
compared to normal controls (n=7). This study employed
the use of statistical parametric mapping to evaluate
changes in Fractional Anisotropy (FA) and found decreased
FA in the superior and middle frontal white matter, pre- and
post-central white matter, and a small area in the right
occipital lobe. Rosas et al. (2006) and Seppi et al. (Seppi et
al. 2006) also employed diffusion tensor imaging to
evaluate brain changes associated with HD. Seppi et al.
evaluated the trace of the diffusion tensor within subcortical
regions of interest and showed an increase in the trace that
was related to disease progression in stage I and II manifest
HD (Seppi et al. 2006). Rosas et al. (2006) evaluated
fractional anisotropy in manifest and preclinical HD
subjects as compared to matched control samples. Regions
of interest were measured for the corpus callosum, internal
capsule, external capsule, and basal ganglia. An exploratory
voxel based analysis was also conducted. Fractional
anisotropy was reduced within the corpus callosum and
the posterior limb of the internal capsule and increases were
seen in the anterior limb of the internal capsule, putamen
and globus pallidus.
The purpose of this study was to replicate and extend the
findings already reported using diffusion tensor derived
measures in a larger sample of preclinical HD participants
and to assess the strength of the associations between DTI
measures and disease progression parameters. We specifi-
cally wanted to examine the variation in DTI in the disease
epoch prior to diagnosis. Such information would inform
efforts to determine markers of disease progression prior to
receiving a diagnosis of manifest disease (when functional
and staging measures are traditionally used in clinical
trials). The estimated five year probability of disease
diagnosis was calculated for each preclinical HD subject
using a validated formula based upon CAG repeat length
and current age (Langbehn et al. 2004).
Methods
Subjects
The study consisted of 31 subjects who had previously
undergone elective independent genetic testing and been
found to have the HD gene mutation. Subjects were
recruited from the HD Registry at the University of Iowa.
Subjects were excluded if they had a history of learning
disorder or mental retardation, unstable medical or psychi-
atric illness, history of alcohol or drug abuse within the
previous year, history of other central nervous system
(CNS) disease or event, or pacemaker or metallic implants.
Diagnosis of HD was determined by a rating of 4 on the
motor portion of the Unified Huntington’s Disease Rating
Scale (UHDRS) following an examination by a movement
disorder specialist. Any gene-expanded participant from the
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HD registry who scored a rating of 4 on the UHDRS was
excluded from the protocol, therefore all participants were
pre-diagnosis or considered preclinical HD. All participants
signed a written informed consent approved by the
University of Iowa institutional review board before
enrollment.
MRI acquisition
Subjects underwent an imaging protocol that collected high
resolution anatomical images and a diffusion tensor
sequence. Images were obtained on a 1.5 T GE Signa
CV/i MR scanner. The high resolution anatomical images
consisted of a T1 weighted volume and proton density
(PD)/T2 images collected with a dual echo fast spin-echo
two dimensional (2D) sequence. The T1 weighted images
were acquired in the axial plane using a spoiled grass
(SPGR) sequence with the following parameters: echo time
(TE)=3 ms, repetition time (TR)=24 ms, flip angle=20°,
number of excitations (NEX)=1, field of view (FOV)=
240×180×192 mm, matrix=256×192×124 (9 min, 30 s).
The PD and T2 weighted images were acquired coronally
using a fast spin-echo dual-echo sequence with the
following parameters: TE=36 (PD) / 96 (T2) ms, TR=
3,000 ms, NEX=1, FOV=260×195 mm, Matrix=256×
192, slice thickness/gap=3.0/0.0 mm, and echo train
length=6 (4 min, 30 s). The diffusion tensor data was
acquired using an echo-planar spin-echo sequence in the
axial plane with the following parameters: TE=100 ms,
TR=6,000 ms, FOV=256×256 mm, Matrix=128×128,
slice thickness/gap=4.0/0.0 mm, number of diffusion
directions=6, and B-values=250, 500, 750, 1,000 (2 min,
30 s).
Image analysis
Processing of the anatomical images was performed using
the BRAINS (Brain Research: Analysis of Images, Net-
works, and Systems) software (Magnotta et al. 2002). The
images were processed using a standard image analysis
pipeline including anterior commissure (AC)-posterior
commissure (PC) alignment, defining of Talairach param-
eters to warp the Talairach grid onto the subject of interest,
tissue classification (Harris et al. 1999), and skull stripping
using an artificial neural network (Magnotta et al. 1999).
The artificial neural network was also used to define
regions of interest for the putamen and caudate in subject
space (Powell et al. 2006).
The diffusion tensor data was analyzed using the Guided
Tensor Restored Anatomical Connectivity Tractography
(GTRACT) (Cheng et al. 2006) software. The diffusion
weighted images were co-registered to the B0 image to
account for motion and eddy current artifacts. A mutual
information metric (D. Mattes et al. 2003; D Mattes et al.
2001) was used to account for differences in signal intensity
between the B0 image and the images with larger B values.
Next the diffusion tensor was estimated from the diffusion
weighted images after applying a 3×3×3 voxel median filter
to the B0 and diffusion weighted images. Diffusion tensor
rotational invariant scalar images of fractional anisotropy
(FA) and mean diffusivity (MD) were generated. The B0
image was then co-registered with the AC-PC aligned T1
weighted image using a two step registration procedure.
First, a six parameter rigid registration (three translations,
three rotations) was used to co-register the B0 image with the
T1 weighted image. Next, a non-linear B-spline registration
was initialized with the rigid transform and used to remove
susceptibility artifacts from the EPI images (Kabus et al.
2004). The transformations resulting from the non-linear
registration were then used to resample the rotationally
invariant scalar measures and the tissue classified image into
the same space as the T1 weighted images.
Diffusion tensor scalar analysis
The AC-PC aligned image for each subject was co-
registered with the Montreal Neurological Institute
(MNI) 152 atlas image using SPM5. The individual T1
weighted scans were warped into the space of the MNI
152 atlas brain. The resulting deformation field was also
used to warp the FA, MD and tissue classified images
that were co-registered with the anatomical T1 weighted
images. After registration to the MNI brain, the FA, MD
and tissue classified images were analyzed using a voxel
based analysis. A 2 mm spatial filter was used to
eliminate residual anatomic variability between subjects.
Linear regressions were performed to determine the
relationship between the image signal intensity and the
five year probability of diagnosis within the next five
years. This analysis was carried out separately for the
FA, MD and tissue classified image sets. The probability
of diagnosis is a function of a subject’s CAG-expansion
length and current age and was calculated using the
survival analysis formula of Langbehn et al. (Langbehn
et al. 2004). We used this diagnosis probability instead of
alternatives such as estimated years to diagnosis because,
empirically, diagnosis probability has consistently yielded
a more linear relationship with other clinical correlates of
HD development using the PREDICT-HD data (Paulsen
et al. 2006; Paulsen et al. 2007). PREDICT-HD is a multi-
site study of over 1,000 participants that investigates the
nature and pattern of neurobiological changes and neuro-
behavioral changes that occur in the period leading up to a
diagnosis of Huntington’s disease. Manually defined
landmark points were placed in the anterior, middle, and
posterior portions of the external capsule. This region had
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previously been shown to exhibit lower FA in patients
with Huntington’s disease as compared to normal controls.
A 3×3×3 mm region was defined using the landmark as
the center of the region. FA was measured within these
9 mm3 locations.
Results
The quality of the registration is shown in Fig. 1. This
figure shows nine randomly selected subjects from the
study. The spatially normalized and smoothed FA maps
are all shown at the same axial slice. The voxel wise
analysis showed two main findings for FA. The first was
that there was significantly decreased fractional anisotropy
in the external capsule bilaterally that was negatively
correlated with the probability of diagnosis (p<0.001,
uncorrected). That is, the FA decreased as the five-year
expected probability of diagnosis increased (Fig. 2a). The
follow-up ROI analysis using the landmark points within
the external capsule did not find any statistically signifi-
cant differences in the external capsule for any of the
regions. The correlations were −0.19, −0.18, and −0.17 for
the anterior, middle and posterior locations respectively.
There was also a significant positive association between
the five year expected probability of diagnosis and FA
within the putamen bilaterally (p<0.001, uncorrected).
That is, that FA increased as the five year probability of
diagnosis increased (Fig. 2b). As a follow up analysis to
the findings in the putamen, a region of interest (ROI)
analysis was conducted using the neural networked
defined regions of the putamen derived from the anatom-
ical images. The average FA within the putamen was
measured in the space of each subject and correlated with
the probability of diagnosis. This resulted in correlations
of 0.56 and 0.60 for the right and left putamen (Fig. 3)
respectively confirming the voxel based results from this
region. Both correlations have a p=.001 by 2-sided 29 d.f.
Fig. 1 Composite image of nine
subjects from the study showing
the FA image same axial slice.
The axial FA images are shown
after smoothing and nonlinear
registration to the MNI152 atlas
space
80 Brain Imaging and Behavior (2009) 3:77–84
t-test against the null hypothesis of no association. Two
rather extreme observations existed in the data. Therefore,
the robustness of the linear correlations was verified by
conservatively recalculating after removing these two
points. Although the magnitude and statistical significance
of the correlations are somewhat reduced, both remain
statistically significant at levels between .01 and .02. The
results of the mean diffusivity also showed a positive
correlation with probability of diagnosis in both the
caudate and putamen bilaterally (Fig. 4). This means that
water mobility within these subcortical structures
increases as one progresses towards disease diagnosis.
There were no negative correlations between MD and
probability of diagnosis. Finally, the tissue classification
shows changes in the border between the caudate and
ventricles and the border between the putamen and ex-
ternal capsule (Fig. 5). This is consistent with other
widely-reported evidence that the size of the caudate and
putamen are shrinking as the subjects progress towards
clinical manifestation of HD. Follow-up region of interest
Fig. 2 The top row shows areas
where the FA values are posi-
tively related to the 5 year
probability of onset (p<0.001,
uncorrected).This is shown
overlaid on the a MNI 152 atlas,
b mean FA with no smoothing,
and c mean FA with a 2 mm
gaussian filter. The bottom row
contains areas where FA was
negatively related to the proba-
bility of onset (p<0.001, uncor-
rected). This was mainly
confined to the external capsule.
The area of significant changes
are shown from left to right
overlaid on the dMNI 152 atlas,
e the mean FA map with no
smoothing, and f the mean FA
map with a 2 mm gaussian filter
Fig. 3 Relationship between the probability of onset and the average FA values within the caudate and putamen using a region of interest
approach. Scatter plots are shown for the left (a) and right (b) putamen
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analysis of the size and mean diffusivity within the
caudate and putamen confirmed this finding. The caudate
volume showed the greatest correlation with probability of
diagnosis (−0.77) while the putamen correlation was
−0.40. The mean diffusivity within the caudate and
putamen were very similar and had positive correlations
between 0.64 and 0.69 for both regions of interest. All
positive and negative relationships are shown by region of
interest in the tables.
Discussion
The use of diffusion tensor imaging in preclinical HD
supports and extends the findings of previous brain
morphology studies showing changes in white matter
before the diagnosis of manifest motor disease. A
number of previous studies have shown reduced white
matter volume and abnormal DTI measures in preclinical
subjects with the Huntington gene expansion (Aylward
et al. 1998; Beglinger et al. 2005; Nopoulos et al. 2007;
Rosas et al. 2003). Reading et al. found focal changes
within the superior frontal, middle frontal and postcentral
white matter (Reading et al. 2005). The work by Rosas et
al. (2006) compared preclinical HD subjects with normal
controls and found decreased FA within the corpus
callosum and internal capsule as well as increased FA in
the putamen and globus pallidus. A voxel based analysis
of these same subjects showed a similar pattern of changes
and included decreased FA in the external capsule and
thalamus. Mean diffusivity was also shown to increase in
the putamen and globus pallidus in the subjects with
clinically diagnosed HD as well as the preclinical HD
subjects as compared to control subjects. No MD changes
were found in the caudate in a region of interest analysis.
While the current study replicates and extends previous
DTI abnormalities by using a larger sample size (over
twice the n of previous studies), we also confirm a signifi-
cant relationship between these diffusion tensor scalar
measures and estimated proximity to HD diagnosis. The
confirmation of this finding is key to current efforts to
establish possible markers of disease progression for use
in preclinical experimental trials. This study does differ
from the work of Rosas et al. in that a positive relationship
between mean diffusivity and probability of diagnosis was
found in the caudate as well as the putamen, while no
changes related to disease progression were manifested in
the globus pallidus.
While this study shows an interesting relationship
between the probability of diagnosis and diffusion tensor
scalar measures, one limitation of the study is the use of
voxel based morphometry as the primary analysis tool. In
this approach, one is measuring residual changes in the
image modalities after nonlinear registration. Diseases that
change brain morphometry may therefore be susceptible to
identifying regions that appear different simply as a result
of increased anatomical variability that is not compensated
by the image registration procedure. In this study, changes
in the FA within the external capsule are susceptible to this
artifact and we are unable to replicate the VBM results in
Fig. 5 Regions of tissue type changes associated with disease
progression (p<0.001, uncorrected). These changes are mainly
confined to the border between the caudate/ventricle and between
the putamen/external capsule
Fig. 4 Shows the regions with
increased mean diffusivity (p<
0.001 uncorrected). Regions
meeting this criteria include the
a cerebellum, b striatum, and c
cortical regions
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the external capsule in a follow-up ROI analysis. Therefore,
the white matter changes within this region appear to be the
result of residual anatomical variability. The VBM based
finding of changes in fractional anisotropy and mean
diffusivity within the caudate and putamen, however, were
followed up with an ROI analysis that confirmed the
findings. We cannot rule out, however, that slight misalign-
ment of the B0 images with the anatomical data or image
distortion of the echo-planar image could result in increased
FAwithin the putamen by placement of the external capsule
within the regions of interest defined on the anatomical
images.
Decreased volume of the striatum has been documented
to occur in preclinical HD individuals many years out from
diagnosis (Aylward et al. 2004). While the increased FA
(interpreted as higher white matter integrity) in the putamen
may seem counterintuitive, a reasonable explanation is that
the loss of grey matter in this region produces a greater
white matter / grey matter ratio. Increased mean diffusivity
has been shown to be related to demyelination axonal loss,
and gliosis. A classic Huntington’s disease manifestation
includes both gliosis and neural loss within the basal
ganglia region. This clearly needs further study. Recent
work by Bartzokis et al. have shown an increase in
oligodendrocytes years in advance of the clinical manifes-
tation of the illness (Bartzokis et al. 2007). The oligoden-
drocytes are responsible for axonal myelination repair.
However, an increased concentration of these cells may
result in free-radical-induced tissue damage due to the large
intracellular iron content. This may also explain the
increased FA within the putamen. It has been shown that
the transition zone between the putamen and globus
pallidus has a large concentration of oligodendrocytes in
primates (Cammermeyer 1960).
Conclusion
This study shows that scalar maps generated from
diffusion tensor imaging may be directly related to the
earliest stages of disease progression within HD, even
before a diagnosis is warranted. Findings suggest that
DTI measures, therefore, may have the ability to act as a
biomarker for disease progression in clinical trials of pre-
manifest subjects.
Tables 1, 2, 3, and 4.
Table 1 Locations with a significant positive relationship (p<0.001,
uncorrected) between FA and five year probability of onset
Region X Y Z
Right Lingual Gryus 8 −96 2
Left Putamen −26 2 4
Right Putamen 24 14 2
Right Insula 38 −18 8
Left Middle Frontal Gyrus −8 58 18
Left Middle Frontal Gyrus −42 48 16
Left Potserior Cingulate −20 −62 12
Left Medial Frontal Gyrus −6 −10 60
Table 2 Locations with a significant negative relationship (p<0.001,
uncorrected) between FA and five year probability of onset
Region X Y Z
Right Middle Frontal Gyrus 18 6 50
Right External Capsule 32 8 4
Left External Capsule −30 6 10
Left External Capsule −32 −10 12
Right Anterior Frontal WM 18 20 40
Table 3 Locations with a significant positive relationship (p<0.001,
uncorrected) between mean diffusivity and the five year probability of
onset
Region X Y Z
Right Putamen 30 −6 10
Left Putamen −32 −10 14
Right Post Central Gyrus 48 −22 52
Left inferior frontal Gyrus −52 24 22
Left Cerebellum WM −12 −50 −34
Right Parahippocampal gyrus 22 −16 −14
Right Parietal WM 22 −32 30
Right Middle Frontal gyrus 14 −22 62
Right Cerebellum 12 −50 −28
Right Cerebellum 52 −58 −20
Table 4 Locations with significant changes (p<0.001, uncorrected) in
tissue classification related to five year probability of onset
Region X Y Z
Left External Capsule −32 4 10
Right WM around Putamen 30 −8 16
Right Parietal Lobe WM 36 −64 18
Right Caudate 12 12 12
Left Middle Frontal Gyrus −52 24 22
Right Post Central Gyrus 50 −20 56
Left Frontal WM −26 12 28
Left Caudate −10 6 0
Right External Capsule 24 −4 32
Right External Capsule 28 18 22
Right Frontal Lobe WM 36 34 10
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